Pharmacokinetic and clinical considerations for monitoring asparaginase activity levels during pegaspargase therapy

Publisher: John Wiley & Sons Inc

E-ISSN: 1545-5017|62|6|1115-1115

ISSN: 1545-5009

Source: PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.6, 2015-06, pp. : 1115-1115

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract